SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 213 filers reported holding SEATTLE GENETICS INC in Q1 2014. The put-call ratio across all filers is 2.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $28,565,000 | +1433.3% | 250,000 | +594.4% | 2.35% | +642.6% |
| Q2 2017 | $1,863,000 | -17.7% | 36,000 | 0.0% | 0.32% | -28.3% |
| Q1 2017 | $2,263,000 | -28.0% | 36,000 | -48.6% | 0.44% | -3.9% |
| Q4 2015 | $3,142,000 | +63.0% | 70,000 | +40.0% | 0.46% | +87.0% |
| Q3 2015 | $1,928,000 | -71.5% | 50,000 | -64.3% | 0.25% | -63.0% |
| Q2 2015 | $6,776,000 | -4.2% | 140,000 | -30.0% | 0.66% | -9.8% |
| Q1 2015 | $7,070,000 | +22.4% | 200,000 | +28.7% | 0.74% | +3.1% |
| Q3 2014 | $5,776,000 | -49.3% | 155,360 | -47.8% | 0.71% | -74.6% |
| Q2 2014 | $11,391,000 | +95.6% | 297,800 | +133.0% | 2.81% | +111.2% |
| Q1 2014 | $5,823,000 | +18.9% | 127,800 | +4.1% | 1.33% | -2.6% |
| Q4 2013 | $4,898,000 | – | 122,800 | – | 1.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
| Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
| Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
| Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
| Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
| Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
| SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
| Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
| Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |